Pharmafile Logo
Pharmafocus logo
Advanced Search

Janssen Healthcare Innovation two-time finalists at eyeforpharma Barcelona Awards

December 17, 2014

Janssen Healthcare Innovation’s Care4Today programme is set to take two of the highest honours at the 2015 eyeforpharma Barcelona Awards …

News
Press release

PM Society names pharma prize finalists

December 17, 2014
Medical Communications, Sales and Marketing GSK, Mundipharma, Shire, VCCP Health, digital awards, pm society

The finalists for the PM Society Awards have been announced today as pharma and med comms agencies gear up to …

News
Cyramza image

Lilly’s lung cancer drug sees FDA approval

December 17, 2014
Sales and Marketing BMS, Cancer, FDA, NSCLC, cyramza, docetaxel, lilly, opdivo, ramucirumab

Eli Lilly’s lung cancer drug Cyramza (ramucirumab) has been shown the green light by the US Food and Drug Administration …

News

Apps & Digital Resources vie for top honour at eyeforpharma Barcelona Awards

December 17, 2014

Two thirds of the finalists for the ‘Most Valuable Patient Initiative’ in the 2015 eyeforpharma Barcelona Awards have used interactive …

News
Press release
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014
Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …

News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

News
Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014
Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …

News
Janssen image

Janssen launches HIV combination pill

December 17, 2014
Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …

News
philippe_bishop_gilead

Gilead secures senior head from Genentech

December 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Gilead, Philippe Bishop

Dr Philippe Bishop is joining the California-based biopharma firm Gilead from Genentech to be the company’s senior vice president of …

Appointment
Pradaxa image

Boehringer gets NICE nod for Pradaxa

December 16, 2014
Sales and Marketing Boehringer, NHS, NICE, Pradaxa, VTE, dagibatran, ingelheim, warfarin

NICE has confirmed a recommendation for Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa, as a treatment for blood clots in …

News
Inlyta image

NICE backs Pfizer’s drug for advanced kidney cancer

December 16, 2014
Sales and Marketing NICE, Pfizer, Sutent, Votrient, Zytiga, axitinib, inlyta, xofigo

UK healthcare guidance body NICE has issued final draft guidance recommending Pfizer’s Inlyta for advanced kidney cancer. The draft recommendation …

News
Signifor image

Novartis hormone disorder drug approved in US

December 16, 2014
Sales and Marketing FDA, Lar, Signifor, acromegaly, cushing, hormone, pasireotide

The FDA has approved Novartis’ Signifor (pasireotide) for the treatment of a rare and life-threatening hormonal disorder. The US Food …

News
Pfizer image

Pfizer buys OPKO growth hormone drug

December 16, 2014
Research and Development, Sales and Marketing Pfizer, ghd, growth, hGH-CTP, hormone, merger, opko

Pfizer will co-develop and commercialise OPKO’s growth hormone deficiency (GHD) drug hGH-CTP in a new agreement between the firms. The …

News
AZ image

AstraZeneca closing US manufacturing unit

December 16, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, Pulmicort, malloy, short haircuts, westboro

AstraZeneca is closing its Otis Street manufacturing plant next year that has been in operation for 33 years, and the …

News
thomas_werner

Riemser Pharma recruits former GSK head

December 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, riemser pharma, thomas werner

Riemser Pharma in Germany has appointed Dr Thomas Werner to its advisory board. The former head of GlaxoSmithKline and Bristol-Myers …

Appointment
Zelboraf image

Roche submits melanoma drug to FDA

December 15, 2014
Sales and Marketing Cobimeinib, FDA, Roche, Zelboraf, mekinist, melanoma, taflinlar, vemurafenib

Roche has submitted its melanoma drug cobimeinib for review with the FDA as it confirms the results of its Phase …

News
Abbott image

Abbott buys Russian firm Veropharm

December 15, 2014
Manufacturing and Production, Sales and Marketing Abbott, Fresenius, cfr pharma, petrovax, sistema, veropharm, zenitco

Abbott has completed its purchase of Russia-based Veropharm in a $305 million deal as it looks to firmly establish itself …

News
Afinitor image

Mixed bag for Novartis and Astellas in breast cancer

December 15, 2014
Research and Development, Sales and Marketing Afinitor, Astellas, Novartis, Xtandi, enzalutamide, everolimus

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …

News
Sovaldi image

Gilead sued over Sovaldi price

December 15, 2014
Sales and Marketing BMS, Gilead, NICE, harvoni, hep C, septa, sofosbuvir, sovaldi

A payer is suing Gilead over the price of its hep-c drug Sovaldi in the US after spending $2.4 million …

News
The Gateway to Local Adoption Series

Latest content

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026